| Pancreatic cancer J Kleeff, M Korc, M Apte, C La Vecchia, CD Johnson, AV Biankin, ... Nature reviews Disease primers 2, 16022, 2016 | 1843 | 2016 |
| Cancer-associated cachexia VE Baracos, L Martin, M Korc, DC Guttridge, KCH Fearon Nature reviews Disease primers 4 (1), 1-18, 2018 | 1195 | 2018 |
| Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells BS Komm, CM Terpening, DJ Benz, KA Graeme, A Gallegos, M Korc, ... Science 241 (4861), 81-84, 1988 | 1137 | 1988 |
| Introduction to strong mixing conditions RC Bradley (No Title), 2007 | 704 | 2007 |
| Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival H Friess, Y Yamanaka, M Büchler, M Ebert, HG Beger, LI Gold, M Korc Gastroenterology 105 (6), 1846-1856, 1993 | 665 | 1993 |
| In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain J Fallon, S Reid, R Kinyamu, I Opole, R Opole, J Baratta, M Korc, TL Endo, ... Proceedings of the National Academy of Sciences 97 (26), 14686-14691, 2000 | 601 | 2000 |
| Action of secretagogues on a new preparation of functionally intact, isolated pancreatic acini JA Williams, M Korc, RL Dormer American Journal of Physiology-Endocrinology And Metabolism 235 (5), E517-524, 1978 | 597 | 1978 |
| Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Y Yamanaka, H Friess, MS Kobrin, M Buchler, HG Beger, M Korc Anticancer research 13 (3), 565-569, 1993 | 527 | 1993 |
| MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors X Liu, LF Sempere, H Ouyang, VA Memoli, AS Andrew, Y Luo, ... The Journal of clinical investigation 120 (4), 1298-1309, 2010 | 476 | 2010 |
| The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Kleeff, T Ishiwata, A Kumbasar, H Friess, MW Büchler, AD Lander, ... The Journal of clinical investigation 102 (9), 1662-1673, 1998 | 450 | 1998 |
| The role of fibroblast growth factors in tumor growth M Korc, RE Friesel Current cancer drug targets 9 (5), 639-651, 2009 | 449 | 2009 |
| Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis H Maruyama, J Kleeff, S Wildi, H Friess, MW Büchler, MA Israel, M Korc The American journal of pathology 155 (3), 815-822, 1999 | 438 | 1999 |
| Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage Y Yamanaka, H Friess, M Buchler, HG Beger, E Uchida, M Onda, ... Cancer research 53 (21), 5289-5296, 1993 | 426 | 1993 |
| Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer PA Hart, MD Bellin, DK Andersen, D Bradley, Z Cruz-Monserrate, ... The lancet Gastroenterology & hepatology 1 (3), 226-237, 2016 | 417 | 2016 |
| Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles U Bergmann, H Funatomi, M Yokoyama, HG Beger, M Korc Cancer research 55 (10), 2007-2011, 1995 | 401 | 1995 |
| The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer J Kleeff, T Ishiwata, H Maruyama, H Friess, P Truong, MW Büchler, D Falb, ... Oncogene 18 (39), 5363-5372, 1999 | 399 | 1999 |
| Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer Z Zhu, H Friess, FF diMola, A Zimmermann, HU Graber, M Korc, ... Journal of Clinical Oncology 17 (8), 2419-2419, 1999 | 359 | 1999 |
| Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders ZW Zhu, H Friess, L Wang, M Abou-Shady, A Zimmermann, AD Lander, ... Gut 48 (4), 558-564, 2001 | 354 | 2001 |
| Pancreatic islet-acinar cell interaction: amylase messenger RNA levels are determined by insulin M Korc, D Owerbach, C Quinto, WJ Rutter Science 213 (4505), 351-353, 1981 | 354 | 1981 |
| Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells K Matsuda, H Maruyama, F Guo, J Kleeff, J Itakura, Y Matsumoto, ... Cancer research 61 (14), 5562-5569, 2001 | 348 | 2001 |
